Acquired antimicrobial resistance in equine Rhodococcus equi isolates.
about
In vitro potential of equine DEFA1 and eCATH1 as alternative antimicrobial drugs in rhodococcosis treatment.Validation and evaluation of VapA-specific IgG and IgG subclass enzyme-linked immunosorbent assays (ELISAs) to identify foals with Rhodococcus equi pneumonia.The equine antimicrobial peptide eCATH1 is effective against the facultative intracellular pathogen Rhodococcus equi in miceMinimum inhibitory concentrations of erythromycin and rifampin for Rhodococcus equi during the years 2007-2014.MICs of 32 antimicrobial agents for Rhodococcus equi isolates of animal origin.Rhodococcus equi hyperimmune plasma decreases pneumonia severity after a randomised experimental challenge of neonatal foals.
P2860
Acquired antimicrobial resistance in equine Rhodococcus equi isolates.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Acquired antimicrobial resistance in equine Rhodococcus equi isolates.
@en
Acquired antimicrobial resistance in equine Rhodococcus equi isolates.
@nl
type
label
Acquired antimicrobial resistance in equine Rhodococcus equi isolates.
@en
Acquired antimicrobial resistance in equine Rhodococcus equi isolates.
@nl
prefLabel
Acquired antimicrobial resistance in equine Rhodococcus equi isolates.
@en
Acquired antimicrobial resistance in equine Rhodococcus equi isolates.
@nl
P356
P1433
P1476
Acquired antimicrobial resistance in equine Rhodococcus equi isolates.
@en
P2093
P356
10.1136/VR.C5289
P407
P577
2011-01-21T00:00:00Z